Recent advances in the management of hepatocellular carcinoma

Liver cancer remains a challenge of global health, being the 4th leading cause of cancer death worldwide. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, and is usually precipitated by chronic viral infections (hepatitis B and C), non-alcoholic steatohepatitis, heavy...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Clinical and Molecular Hepatology Ročník 30; číslo 1; s. 1 - 15
Hlavní autori:	Sankar, Kamya, Gong, Jun, Osipov, Arsen, Miles, Steven A., Kosari, Kambiz, Nissen, Nicholas N., Hendifar, Andrew E., Koltsova, Ekaterina K., Yang, Ju Dong
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Korea (South) The Korean Association for the Study of the Liver 01.01.2024 Korean Association for the Study of the Liver 대한간학회
Predmet:	Ablation Cancer therapies Carcinoma Carcinoma, Hepatocellular - etiology Carcinoma, Hepatocellular - therapy Diseases of the digestive system. Gastroenterology FDA approval Hepatitis B Hepatitis B - complications Hepatitis C Hepatocellular Hepatocellular carcinoma Humans Immunotherapy Kinases Liver cancer Liver Cirrhosis Liver Cirrhosis - complications Liver Neoplasms Liver Neoplasms - complications Liver transplants Medical prognosis RC799-869 Response rates Review Tyrosine protein kinase inhibitors 내과학 United States > US Liver cancer Hepatocellular carcinoma Tyrosine protein kinase inhibitors Immunotherapy
ISSN:	2287-2728, 2287-285X, 2287-285X
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!